AlphaRx Canada to Merge with Pacific Orient

AlphaRx, Inc. announced that its newly formed China subsidiary, AlphaRx Canada, signed a non-binding letter of intent to execute a reverse merger with Pacific Orient Capital, listed on the Toronto Venture Exchange. The new company, which will be known as Pacific Orient Biopharma Group, will focus on branded generic drug development and distribution in China as well as other emerging markets. More details... Stock Symbol: (OTCBB: ALRX)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.